As a founding partner of Kirkegaard and Perry Laboratories, Dr. Leslie Kirkegaard (right) has a 25-year record of successful product discovery. His work involved the induction and purification of serum antibodies, the conjugation of these antibodies to enzymes and chromophores, and the use of these conjugates in ultra-sensitive assay systems. In recent years his work has progressed to include the production of gold sol conjugates and the optimization of lateral flow assays. Leslie Kirkegaard serves as Vice President of Research and Development. Email lkirkegaard@bioassayworks.com. Glen Ford (center) comes to BioAssay Works with 30 years of experience in the laboratory, and with more than 15 years of experience in development and production of lateral flow assay systems. He developed lateral-flow assays for the antibodies induced by numerous viral and bacterial agents in blood, serum, saliva, and urine. He recently developed lateral-flow tests for HIV (AIDS) that are capable of detecting HIV antibody in urine where it is present in concentrations over 1000-fold less than in serum. Glen Ford serves BioAssay Works as Vice President of Operations. Email gford@bioassayworks.com A founding partner of BioFX Laboratories, Inc., Stephen Mefferd (left) comes to BioAssay Works with more than 25 years of experience in the sales of biological products. He is strategically placed to introduce customers world-wide to the products and services offered by BioAssay Works. Stephen Mefferd serves BioAssay Works as Vice President of Business Development. Email smefferd@bioassayworks.com. In the Company''s elegant solution to the problems of gold sol technology and gold-sol-based rapid assays, BioAssay Works has taken nanoparticle chemistry to the level of art.
我们专注于开发生产胶体金检测和基于胶体金的快速检测。 |
